Open access
73
Views
7
CrossRef citations to date
0
Altmetric
Original Research
Partial response to proton pump inhibitor therapy for GERD: observational study of patient characteristics, burden of disease, and costs in the USA
Nils-Olov Stålhammar1 Payer Evidence, AstraZeneca R&D, Mölndal, SwedenCorrespondence[email protected]
, Brennan M Spiegel2 Department of Gastroenterology, VA Greater Los Angeles Healthcare System;3 David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
, Helena Granstedt Löfman1 Payer Evidence, AstraZeneca R&D, Mölndal, Sweden
, Maria Karlsson1 Payer Evidence, AstraZeneca R&D, Mölndal, Sweden
, Peter Wahlqvist1 Payer Evidence, AstraZeneca R&D, Mölndal, Sweden
, Jørgen Næsdal4 Medical Department, AstraZeneca R&D, Mölndal, Sweden
, M Todd Nelson5 Late Phase, Life Sciences, OptumInsight, Raleigh, NC, USA
& Nicolas Despiégel6 HEOR, OptumInsight, Nanterre, France
show all
Pages 57-67
|
Published online: 06 Dec 2012
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.